Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease

Clinical trial NCT07273721 · RECRUITING

Trial details

NCT number: NCT07273721
Sponsor: Medical University of Vienna
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Von Willebrand Disease (VWD), Type 2

Start date: 2025-08-14
Primary completion: 2026-07-31
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.